Drug Trial Radar · NCT06122779
Study to Evaluate Safety, Tolerability and Drug Levels of BMS-986435/MYK-224 in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF)
Last checked: Nov 19, 2026Latest source record: Jul 30, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
227
Actual
Start
Nov 7, 2023
Primary completion
Dec 14, 2026
Study completion Dec 14, 2026
Sponsor
- Lead sponsor
- Bristol-Myers SquibbBristol Myers Squibb (BMY)
- Sponsor type
- Industry
- First posted
- Nov 8, 2023
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Sequential
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 40 years, up to 85 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the safety, tolerability, and exposure-response (E-R) of BMS-986435/MYK-224 in participants with symptomatic Heart Failure with Preserved Ejection Fraction (HFpEF).
Conditions
- Heart Failure
Interventions
BMS-986435Drug
Specified dose on specified days
PlaceboOther
Specified dose on specified days
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence of treatment emergent adverse events (TEAEs)Time frame: Up to approximately 24 weeks
- Incidence of serious adverse events (SAEs)Time frame: Up to approximately 24 weeks
- Incidence of AEs leading to treatment discontinuationTime frame: Up to approximately 20 weeks
Locations
86 sites in 11 countries. Site status is shown where the registry gives one.
Local Institution - 0002
Birmingham, Alabama
Local Institution - 0096
Lakewood, Colorado
Local Institution - 0077
Jacksonville, Florida
Local Institution - 0003
Miami, Florida
Local Institution - 0099
Miami, Florida
Local Institution - 0004
Chicago, Illinois
Local Institution - 0005
Hazel Crest, Illinois
Local Institution - 0029
Indianapolis, Indiana
Local Institution - 0028
St Louis, Missouri
Local Institution - 0117
Hackensack, New Jersey
Local Institution - 0070
Albany, New York
Local Institution - 0105
Brooklyn, New York
Local Institution - 0008
New York, New York
Local Institution - 0059
Rochester, New York
Local Institution - 0076
Rochester, New York
Local Institution - 0094
Rosedale, New York
Local Institution - 0095
Durham, North Carolina
Local Institution - 0016
Oklahoma City, Oklahoma
Local Institution - 0078
Abington, Pennsylvania
Local Institution - 0001
Tullahoma, Tennessee
Local Institution - 0104
Austin, Texas
Local Institution - 0036
Dallas, Texas
Local Institution - 0015
Houston, Texas
Local Institution - 0060
Buenos Aires, Argentina
Local Institution - 0067
Buenos Aires, Argentina
Local Institution - 0074
Córdoba, Argentina
Local Institution - 0069
Salta, Argentina
Local Institution - 0102
Santa Fe, Argentina
Local Institution - 0054
Ciudad del Libertador General San Martin, Buenos Aires, Argentina
Local Institution - 0115
Zárate, Buenos Aires, Argentina
Local Institution - 0090
Córdoba, Córdoba Province, Argentina
Local Institution - 0053
Córdoba, Córdoba Province, Argentina
Local Institution - 0073
Rosario, Santa Fe Province, Argentina
Local Institution - 0061
San Miguel de Tucumán, Tucumán Province, Argentina
Local Institution - 0007
Hamilton, Ontario, Canada
Local Institution - 0037
Toronto, Ontario, Canada
Local Institution - 0089
Beijing, Beijing Municipality, China
Local Institution - 0087
Guangzhou, Guangdong, China
Local Institution - 0080
Luoyang, Henan, China
Local Institution - 0079
Changsha, Hunan, China
Showing 40 of 86 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.